These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1371159)

  • 1. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Turski L; Jacobsen P; Honoré T; Stephens DN
    J Pharmacol Exp Ther; 1992 Feb; 260(2):742-7. PubMed ID: 1371159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam.
    Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1215-20. PubMed ID: 8263782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
    Wrathall JR; Teng YD; Choiniere D
    Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
    Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
    J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons.
    Wang T; French ED
    Synapse; 1993 Mar; 13(3):270-7. PubMed ID: 7684531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of LY215490, a competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist, on the micturition reflex in the rat.
    Yoshiyama M; Roppolo JR; de Groat WC
    J Pharmacol Exp Ther; 1997 Feb; 280(2):894-904. PubMed ID: 9023304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR; Teng YD; Marriott R
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.
    Meldrum BS; Craggs MD; Dürmüller N; Smith SE; Chapman AG
    Epilepsy Res Suppl; 1992; 9():307-11. PubMed ID: 1337444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466.
    Stephens DN; Brown G
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1914-20. PubMed ID: 10630610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant action of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline in immature rats: comparison with the effects on motor performance.
    Mares P; Mikulecká A; Pometlová M
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1120-6. PubMed ID: 9190844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.
    Tortorella A; Halonen T; Sahibzada N; Gale K
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1401-5. PubMed ID: 9067329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spastic long-lasting reflexes of the chronic spinal rat studied in vitro.
    Li Y; Harvey PJ; Li X; Bennett DJ
    J Neurophysiol; 2004 May; 91(5):2236-46. PubMed ID: 15069101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.
    Boldry RC; Kelland MD; Engber TM; Chase TN
    Brain Res; 1993 Jan; 600(2):331-4. PubMed ID: 7679606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys.
    Klockgether T; Turski L; Honoré T; Zhang ZM; Gash DM; Kurlan R; Greenamyre JT
    Ann Neurol; 1991 Nov; 30(5):717-23. PubMed ID: 1662477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.